Vedere Bio II to Present Two Abstracts at the ASGCT 2022 Annual Meeting
CAMBRIDGE, Mass., May 2, 2022 /PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision resto...
United Kingdom United States Prnewswire Vedere Bio Ii Inc Mission Biocapital Meeting Of The American Society Gene Development Or Manufacturing
Source: businessinsider.com